Neovii
Josef Hruska is an accomplished medical affairs professional with over 30 years of experience in the pharmaceutical and healthcare sectors. Currently serving as Head Medical Science at Neovii since September 2019, Josef has previously held significant roles including Chief Scientific Officer ad interim and Senior Director Medical Affairs, Global. Notable positions include Senior International Medical Director at Roche, Executive Medical Director at EffRx Pharmaceuticals, Regional Medical Director at Takeda Pharmaceuticals, and Global Brand Medical Director at Novartis. Josef's extensive background encompasses leadership in medical strategy development, clinical trial management, and stakeholder collaboration across major pharmaceutical companies, supported by a Doctor of Medicine (M.D.) degree from Charles University.
This person is not in the org chart
This person is not in any teams
Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.